461 related articles for article (PubMed ID: 12493698)
21. The proteolytic activity of pregnancy-associated plasma protein-A is potentially regulated by stanniocalcin-1 and -2 during human ovarian follicle development.
Jepsen MR; Kløverpris S; Bøtkjær JA; Wissing ML; Andersen CY; Oxvig C
Hum Reprod; 2016 Apr; 31(4):866-74. PubMed ID: 26874357
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A.
Laursen LS; Overgaard MT; Søe R; Boldt HB; Sottrup-Jensen L; Giudice LC; Conover CA; Oxvig C
FEBS Lett; 2001 Aug; 504(1-2):36-40. PubMed ID: 11522292
[TBL] [Abstract][Full Text] [Related]
23. Pregnancy-associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane.
Sun IY; Overgaard MT; Oxvig C; Giudice LC
J Clin Endocrinol Metab; 2002 Nov; 87(11):5235-40. PubMed ID: 12414897
[TBL] [Abstract][Full Text] [Related]
24. Regulation of ovarian folliculogenesis by IGF and BMP system in domestic animals.
Monget P; Fabre S; Mulsant P; Lecerf F; Elsen JM; Mazerbourg S; Pisselet C; Monniaux D
Domest Anim Endocrinol; 2002 Jul; 23(1-2):139-54. PubMed ID: 12142233
[TBL] [Abstract][Full Text] [Related]
25. Proteolytic degradation of insulin-like growth factor binding proteins by ovarian follicles: a control mechanism for selection of dominant follicles.
Spicer LJ
Biol Reprod; 2004 May; 70(5):1223-30. PubMed ID: 14668213
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factors-I and -II and insulin-like growth factor-binding protein-2 in dominant equine follicles during spring transition and the ovulatory season.
Watson ED; Bae SE; Thomassen R; Thomson SR; Woad K; Armstrong DG
Reproduction; 2004 Sep; 128(3):321-9. PubMed ID: 15333783
[TBL] [Abstract][Full Text] [Related]
27. Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability.
Yan X; Baxter RC; Firth SM
J Clin Endocrinol Metab; 2010 Mar; 95(3):1412-20. PubMed ID: 20103653
[TBL] [Abstract][Full Text] [Related]
28. Pregnancy-associated plasma protein A in human ovarian follicles and its association with intrafollicular hormone levels.
Bøtkjær JA; Jeppesen JV; Wissing ML; Kløverpris S; Oxvig C; Mason JI; Borgbo T; Andersen CY
Fertil Steril; 2015 Nov; 104(5):1294-301.e1. PubMed ID: 26297643
[TBL] [Abstract][Full Text] [Related]
29. Expression of recombinant murine pregnancy-associated plasma protein-A (PAPP-A) and a novel variant (PAPP-Ai) with differential proteolytic activity.
Søe R; Overgaard MT; Thomsen AR; Laursen LS; Olsen IM; Sottrup-Jensen L; Haaning J; Giudice LC; Conover CA; Oxvig C
Eur J Biochem; 2002 Apr; 269(8):2247-56. PubMed ID: 11985604
[TBL] [Abstract][Full Text] [Related]
30. A potential role for insulin-like growth factor binding protein-4 proteolysis in the establishment of ovarian follicular dominance in cattle.
Rivera GM; Chandrasekher YA; Evans AC; Giudice LC; Fortune JE
Biol Reprod; 2001 Jul; 65(1):102-11. PubMed ID: 11420229
[TBL] [Abstract][Full Text] [Related]
31. IGFBP-4 degradation by pregnancy-associated plasma protein-A in MC3T3 osteoblasts.
Bunn RC; Green LD; Overgaard MT; Oxvig C; Fowlkes JL
Biochem Biophys Res Commun; 2004 Dec; 325(3):698-706. PubMed ID: 15541345
[TBL] [Abstract][Full Text] [Related]
32. Studies on regulation of IGF (insulin-like growth factor)-binding protein (IGFBP) 4 proteolysis by pregnancy-associated plasma protein-A (PAPP-A) in cells treated with phorbol ester.
Sivanandam AS; Mohan S; Kita H; Kapur S; Chen ST; Linkhart TA; Bagi G; Baylink DJ; Qin X
Biochem J; 2004 Apr; 379(Pt 1):57-64. PubMed ID: 14705967
[TBL] [Abstract][Full Text] [Related]
33. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor.
Overgaard MT; Haaning J; Boldt HB; Olsen IM; Laursen LS; Christiansen M; Gleich GJ; Sottrup-Jensen L; Conover CA; Oxvig C
J Biol Chem; 2000 Oct; 275(40):31128-33. PubMed ID: 10913121
[TBL] [Abstract][Full Text] [Related]
34. Estrogen- but not androgen-dominant human ovarian follicular fluid contains an insulin-like growth factor binding protein-4 protease.
Chandrasekher YA; Van Dessel HJ; Fauser BC; Giudice LC
J Clin Endocrinol Metab; 1995 Sep; 80(9):2734-9. PubMed ID: 7545699
[TBL] [Abstract][Full Text] [Related]
35. Development of codominant follicles in cattle is associated with a follicle-stimulating hormone-dependent insulin-like growth factor binding protein-4 protease.
Rivera GM; Fortune JE
Biol Reprod; 2001 Jul; 65(1):112-8. PubMed ID: 11420230
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of pregnancy associated plasma protein (PAPP)-A during pregnancy in human and mouse.
Qin X; Sexton C; Byun D; Strong DD; Baylink DJ; Mohan S
Growth Horm IGF Res; 2002 Oct; 12(5):359-66. PubMed ID: 12213189
[TBL] [Abstract][Full Text] [Related]
37. The IGF system in the neonatal ovine uterus.
Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
[TBL] [Abstract][Full Text] [Related]
38. Messenger ribonucleic acid for insulin-like growth factors-I and -II, insulin-like growth factor-binding protein-2, gonadotropin receptors, and steroidogenic enzymes in porcine follicles.
Yuan W; Lucy MC; Smith MF
Biol Reprod; 1996 Nov; 55(5):1045-54. PubMed ID: 8902216
[TBL] [Abstract][Full Text] [Related]
39. IGF dependent modulation of IGF binding protein (IGFBP) proteolysis by pregnancy-associated plasma protein-A (PAPP-A): multiple PAPP-A-IGFBP interaction sites.
Gaidamauskas E; Gyrup C; Boldt HB; Schack VR; Overgaard MT; Laursen LS; Oxvig C
Biochim Biophys Acta; 2013 Mar; 1830(3):2701-9. PubMed ID: 23671931
[TBL] [Abstract][Full Text] [Related]
40. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.
Fowlkes JL; Thrailkill KM; George-Nascimento C; Rosenberg CK; Serra DM
Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
